Clinical Trial Update: Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study [Phase 2]

View source ↗

Summary

This clinical trial update reports safety and efficacy findings from an 18-month Phase 2 study of POMx Capsules in men with recurrent prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• POMx Capsules

Snippet

Sponsor: POM Wonderful LLC | Conditions: Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED